If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

AGM Trading Update

16 Mar 2022 07:00

RNS Number : 8923E
IDOX PLC
16 March 2022
 

16 March 2022

Idox plc

("Idox" or "the Group")

 

AGM Trading update

 

Continued resilient performance

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, is pleased to issue a trading update ahead of today's Annual General Meeting (AGM) for the period 1 November 2021 to date.

 

Highlights for the period include:

 

· Continued resilient operational and financial performance, in line with the Board's expectations.

 

· Order book visibility remains strong, underpinning our confidence.

 

· The Group secured new contract wins and extensions in the period across both our Public Sector Software and Engineering Information Management businesses.

 

· Acquisitions completed in 2021 are integrating well and to plan; good line of sight over an attractive M&A pipeline.

 

· Further to the announcement dated 21 February 2022, Anoop Kang joins the Board and assumes the position of Chief Financial Officer of Idox following the conclusion of today's AGM. He is succeeding Rob Grubb who is taking up a newly created role focussed on advancing the Group's inorganic growth strategy.

 

A further trading update will be issued following the half year ending 30 April 2022.

 

David Meaden, Chief Executive Officer, said:

 

"The business is performing in line with our expectations for the half year and integration of the three businesses acquired in 2021 is on track. Whilst we are cognisant of the current geo-political uncertainties, and the challenges of recruiting talent across the industry, we are well positioned to accelerate the 'fly' phase of our journey. The Group is making good progress against its plans for 2022 and anticipates delivering further growth over the medium term."

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Edward Knight

Paul Gillam

James Smith

 

+44 (0) 20 7418 8900

MHP Communications

Reg Hoare

James Bavister

Harry Clarke

 

+ 44 (0) 203 128 8170

idox@mhpc.com

 

 

About Idox plc

For more information see Idox | Software Built on Insight (idoxgroup.com).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBCGDXBBBDGDU
Date   Source Headline
31st Mar 20257:00 amRNS2025 AGM Trading update
18th Mar 20259:11 amRNSHolding(s) in Company
17th Mar 20257:00 amRNSEstablishment of EBT and Total Voting Rights
13th Mar 202510:48 amRNSHolding(s) in Company
10th Mar 20253:25 pmRNSHolding(s) in Company
7th Mar 20252:39 pmRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPosting of Annual Report and Notice of AGM
24th Feb 20252:36 pmRNSHolding(s) in Company
24th Feb 20257:01 amRNSHolding(s) in Company
24th Feb 20257:00 amRNSHolding(s) in Company
19th Feb 20257:00 amRNSCorrection of payment date for dividend
10th Feb 20257:00 amRNSAppointment of Senior Independent Director
28th Jan 20257:00 amRNSFinal Results
14th Jan 20257:00 amRNSNotice of Final Results
6th Jan 20257:00 amRNS-RIdox Secures Election Services Contract in Malta
20th Dec 202410:43 amRNSHolding(s) in Company
26th Nov 20247:00 amRNSFull Year 2024 Trading Update
13th Nov 202411:55 amRNSHolding(s) in Company
12th Nov 202410:09 amRNSHolding(s) in Company
28th Oct 20244:49 pmRNSHolding(s) in Company
25th Oct 20247:16 amRNSDirectorate Change
27th Sep 20243:26 pmRNSHolding(s) in Company
25th Sep 20244:28 pmRNSHolding(s) in Company
23rd Sep 20244:00 pmRNSHolding(s) in Company
2nd Sep 20243:42 pmRNSHolding(s) in Company
21st Aug 20245:30 pmRNSExercise of Share Options & Total Voting Rights
7th Aug 20245:20 pmRNSHolding(s) in Company
6th Aug 20242:51 pmRNSHolding(s) in Company
29th Jul 20247:00 amRNSDirector Appointment
11th Jun 20247:00 amRNSHalf Year Results
6th Jun 20247:00 amRNSExercise of Share Options & Total Voting Rights
24th May 20243:06 pmRNSHolding(s) in Company
22nd May 20247:00 amRNSHalf Year 2024 Trading Update
9th May 20247:00 amRNSIssue and Allotment of Consideration Shares
24th Apr 20247:00 amRNSReplacement: Total Voting Rights
17th Apr 202412:43 pmRNSTotal Voting Rights
28th Mar 20245:22 pmRNSHolding(s) in Company
28th Mar 202412:37 pmRNSDirector/PDMR Shareholding
28th Mar 202411:21 amRNSResult of AGM
28th Mar 20247:00 amRNSAGM Trading update
22nd Mar 20245:42 pmRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSTotal Voting Rights
11th Mar 20248:40 amRNSHolding(s) in Company
8th Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Mar 20245:12 pmRNSPosting of Annual Report and Notice of AGM
14th Feb 20241:39 pmRNSHolding(s) in Company
9th Feb 20247:00 amRNSExercise of Share Options & Total Voting Rights
25th Jan 20247:00 amRNSFinal Results
18th Jan 202412:35 pmRNSNotice of Final Results
17th Jan 20247:00 amRNSExercise of Share Options & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.